You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nicotinic Acetylcholine Receptor Antagonist

Showing 1 - 25 of 8,304
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDD, Treatment Resistant Depression, Depression Trial in United States (AXS-05)

Completed
Has Results
  • Major Depressive Disorder
  • +2 more
  • AXS-05 (dextromethorphan and bupropion) oral tablets
  • Phoenix, Arizona
  • +50 more
Sep 16, 2022

Smoking, Schizophrenia Trial in New Haven (Physostigmine)

Completed
  • Smoking
  • Schizophrenia
  • New Haven, Connecticut
  • +2 more
Oct 24, 2022

Depression, MDD Trial in United States (AXS-05, Placebo)

Completed
  • Depression
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +42 more
Sep 22, 2021

Alcohol Drinking Trial run by the NIAAA (Alcohol (Oral), Alcohol (IV), Alcohol (Ethanol))

Recruiting
  • Alcohol Drinking
  • Alcohol (Oral)
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 5, 2023

Neuromuscular Blockade Trial in Geneva, Sion (Magnesium Sulfate)

Recruiting
  • Neuromuscular Blockade
  • Magnesium Sulfate
  • Geneva, Canton Of Geneva, Switzerland
  • +1 more
Jul 1, 2021

Vagus Nerve Stimulation Trial in Manhasset (Transcutaneous electrical auricular vagus nerve stimulation (VNS))

Terminated
  • Vagus Nerve Stimulation
  • Transcutaneous electrical auricular vagus nerve stimulation (VNS)
  • Manhasset, New York
    Northwell Health
Dec 12, 2022

Tobacco Use Disorder, Tobacco Smoking Trial in Baltimore ([F18]-ASEM

Recruiting
  • Tobacco Use Disorder
  • Tobacco Smoking
  • [F18]-ASEM (3-(1,4-diazabicyclo[3.2.2]nonan-4-yl)-6-[18F]fluorodibenzo[b,d]thiophene 5,5-dioxide)
  • Contingency Management
  • Baltimore, Maryland
    Johns Hopkins Behavioral Pharmacology Research Unit
Jun 7, 2022

Electronic Cigarette Use Trial in New Haven (Low strength nicotine e-liquid, High strength nicotine e-liquid)

Recruiting
  • Electronic Cigarette Use
  • Low strength nicotine e-liquid
  • High strength nicotine e-liquid
  • New Haven, Connecticut
    Yale University School of Medicine
Feb 8, 2022

Schizophrenia, Impulsive Behavior Trial in Nashville (Nicotine Patch, 7 Mg/24 Hr, Placebo patch)

Terminated
Has Results
  • Schizophrenia
  • Impulsive Behavior
  • Nicotine Patch, 7 Mg/24 Hr
  • Placebo patch
  • Nashville, Tennessee
    Vanderbilt Psychiatric Hospital
Apr 27, 2022

Depressive Disorder Trial in Nashville (Transdermal Nicotine Patch, Transdermal Placebo Patch)

Not yet recruiting
  • Depressive Disorder
  • Transdermal Nicotine Patch
  • Transdermal Placebo Patch
  • Nashville, Tennessee
    Vanderbilt Psychiatric Hosptial
Feb 14, 2023

Hot Flashes, Breast Cancer Trial in Little Rock (solifenacin, Clonidine)

Active, not recruiting
  • Hot Flashes
  • Breast Cancer
  • Little Rock, Arkansas
    Winthrop P. Rockefeller Cancer Institute, University of Arkansas
Jun 8, 2022

Brain Nicotine Receptor Density in Veteran Smokers

Completed
Has Results
  • Positron Emission Tomography
  • positron emission tomography scan
  • San Diego, California
  • +1 more
Oct 4, 2019

Magnesium, Intraoperative Analgesia Trial (Magnesium Sulfate, Propofol)

Not yet recruiting
  • Magnesium
  • Intraoperative Analgesia
  • (no location specified)
Nov 12, 2023

Depressive Disorder Trial in Nashville (Transdermal Nicotine patch)

Not yet recruiting
  • Depressive Disorder
  • Transdermal Nicotine patch
  • Nashville, Tennessee
    Vanderbilt Psychiatric Hospital
Feb 28, 2023

Schizophrenia, Schizoaffective Disorder, Healthy Trial in New Haven (11C-EMO - A Novel PET Radiotracer for Muscarinic M1

Recruiting
  • Schizophrenia
  • +2 more
  • 11C-EMO - A Novel PET Radiotracer for Muscarinic M1 Receptor
  • New Haven, Connecticut
    Connecticut Mental Health Center
Sep 16, 2022

Generalized Myasthenia Gravis Trial in Spain, United States (ALXN1720, Placebo)

Recruiting
  • Generalized Myasthenia Gravis
  • ALXN1720
  • Placebo
  • Gainesville, Georgia
  • +7 more
Dec 20, 2022

Anesthesia, General, Neuromuscular Transmission Disorders Trial in Brussels (Sevoflurane, Propofol)

Recruiting
  • Anesthesia, General
  • Neuromuscular Transmission Disorders
  • Brussels, Belgium
    CHU Brugmann
Jan 19, 2023

PONV in Laparoscopic Cholocystectomies Trial in Larissa (Dimenhydrinate Tablets, Ondansetron iv)

Completed
  • PONV in Laparoscopic Cholocystectomies
  • Dimenhydrinate Tablets
  • Ondansetron iv
  • Larissa, Thessaly, Greece
    University Hospital of Larisa, Department of Anesthesiology
Dec 7, 2022

Receptor Blockade Trial in Fort Collins (Adenosine Triphosphate, Acetylcholine, Sodium Nitroprusside)

Completed
  • Receptor Blockade
  • Adenosine Triphosphate
  • +8 more
  • Fort Collins, Colorado
    Human Performance and Clinical Research Laboratory
Jul 26, 2021

Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR

Not yet recruiting
  • Pericarditis
  • IL1RA Antibody Assay
  • suPAR Testing
  • Homburg, Germany
  • +8 more
Jun 22, 2023

Preemptive Analgesia, Dexmedetomidine, Ketamine Trial in Kafr Ash Shaykh (Dexmedetomidine, Ketamine, Magnesium sulphate)

Not yet recruiting
  • Preemptive Analgesia
  • +5 more
  • Kafr Ash Shaykh, Karelsheikh, Egypt
    Karelsheikh University Hospital
Apr 19, 2023

Opioid-Induced Constipation Trial in Leuven (Naloxegol, codeine phosphate, Placebo)

Completed
  • Opioid-Induced Constipation
  • Leuven, Vlaams-Brabant, Belgium
    UZ Leuven
Mar 15, 2023

Healthy Volunteers Trial in Baltimore (PC14586, Rabeprazole, Famotidine)

Not yet recruiting
  • Healthy Volunteers
  • Baltimore, Maryland
    Parexel International
Sep 19, 2023

atoGepant In reaAl Life iN iTaly

Not yet recruiting
  • Migraine, Prophylaxis
  • (no location specified)
Nov 13, 2023

Autism Spectrum Disorder, Aggression, Irritability Trial in New Haven (Transdermal nicotine, Transdermal )

Completed
Has Results
  • Autism Spectrum Disorder
  • +2 more
  • Transdermal nicotine
  • Transdermal placebo
  • New Haven, Connecticut
    Yale University
May 4, 2022